The Canadian Movement Disorder Group
Drug Induced Movement Disorders


A List of Drugs and the Movement Disorders They Cause

Acute Dystonic Reaction

Withdrawl Emergent Dyskinesia

Acute Akathesia

Oculogyric Crisis

Acute Parkinsonism

Tardive Stereotypies / Dyskinesia

Neuroleptic Malignant Syndrome

Other Tardive Movement Disorders

The infomation contained in the above links in part comes from these references:

Armstrong M, Daly AK, Blennerhassett R, et al: Antipsychotic drug induced movement disorders in schizophrenics in relation to CYP2D6 genotype. Br J Psychiatry; 170:23 -6, 1997

 Barak Y, Swartz M, Shamir E, et al: Vitamin E (alpha-tochopherol) in the treatment of dyskinesia: a meta-analysis. Ann Clin Psychiatry; 10(3):101-5, 1998

 Diederich NJ, Goetz CG: Drug induced movement disorders. Neuro Clin North Am 16(1) 125-139,1998

Kiriakakis V, Bhatia KP, Quinn NP, et al: The natural history of tardive dystonia. Brain; 121(pt11):2053-66, 1998

 Miller LG, Jankovic J, Kane JM, et al. In: Joseph AB, Young RR eds. Movement Disorders in Neurology and Neuropsychiatry, Part 1 chapters 1-21; Blackwell Scientific Publications, 1992

 Nisijima K, Shimizu M, Ishiguro T: Treatment of tardive dystonia with an antispastic agent. Acta Psychiatr Scand; 98(4):341-3, 1998

 Shapleske J, Mickay AP, Mckenna PJ Successful treatment of tardive dystonia with clozapine and clonazepam. Br J Psychiatry;168(4):516-8, 1996

 Steen VW, Lovelie R, MacEwan T, et al: Dopamine D3-receptor gene variant and succeptability to tardive dyskinesia: Mol Psychiatry; 2(2):139-45, 1997

 Sutcher H, Soderstrom J, Perry RD:Tardive dyskinesia: dental prosthetic therapy. Panminerva Med;40(2):154-6,1998

 Tarsy D, Kaufman D, Sethi KD, Rivner MH, Molho E, Factor S An open-label study of botulinum toxin A for treatment oftardive dystonia. Clin Neuropharmacol; 20(1):90 -93,1997

 Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT, Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia. Am J Psychiatry; 155(9):1207-13,1998

 Tu JB, Psychopharmacogenic basis of medication induced movement disorders. International Clinical Psychopharmacology; 12: 1-12, 1997

 Wirshing DA, Bartzokis G, Wirshing WC, et al: Tardive dyskinesia and serum iron indices. Biol Psychiatry; 44(5):493-8, 1998

 Woerner MG, Saltz BL, Kane JM, et al: Diabetes and development of tardive dyskinesia. Am J Psychiatry; 150(6):966-8, 1993

Back to Home Page